Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.
Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.
Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.
Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.
Registry search results
Matching records; showing 10 on this page, newest registry updates first. Search checked 2026-11-08 17:44 UTC. Counts are registry matches, not unique peptides or a worldwide total.
Start: 2004-03-01. Completion: 2006-06-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teduglutide (ALX-0600) (drug) — also listed as: teduglutide
Where the study takes place — 24 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Advanced Clinical Therapeutics Tucson, Arizona, United States Site recruitment: Not reported
Lakewood, Colorado, United States
Explore the world’s study registries
These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.
Start: 2018-08-31. Completion: 2020-09-24 (may be estimated). Results are posted in this registry.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teduglutide (drug)
Standard Medical Therapy (other)
Syringe (device)
Needle (device)
Where the study takes place — 8 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Helsingin yliopistollinen keskussairaala Helsinki, Finland Site recruitment: Not reported
Groupe Hospitalier Pellegrin - Hôpital des Enfants Bordeaux, Gironde, France Site recruitment: Not reported
Hopital Jeanne de Flandre - CHRU Lille Lille, Nord, France Site recruitment: Not reported
Ospedale Pediatrico Bambino Gesù Roma, Italy Site recruitment: Not reported
Great Ormond Street Hospital for Children London, Greater London, United Kingdom Site recruitment: Not reported
Royal Manchester Children's Hospital Manchester, Greater Manchester, United Kingdom Site recruitment: Not reported
Alder Hey Childrens Hospital Liverpool, Merseyside, United Kingdom Site recruitment: Not reported
Birmingham Children's Hospital Birmingham, West Midlands, United Kingdom Site recruitment: Not reported
Start: 2019-05-01. Completion: 2022-05 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
TED + glucose (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Tornto General Hospital, UHN Toronto, Ontario, Canada Site recruitment: Recruiting
Start: 2016-06-01. Completion: 2020-06-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teduglutide (drug)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Start: 2020-09-01. Completion: 2022-09 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teduglutide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Charite University, Berlin, Germany Berlin, Germany Site recruitment: Recruiting
Start: 2018-07-06. Completion: 2019-08-06 (may be estimated). Results are posted in this registry.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teduglutide (drug)
Syringe (device)
Needle (device)
Vial Adapter for Device (device)
Where the study takes place — 5 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Hiroshima University Hospital Hiroshima, Hiroshima, Japan Site recruitment: Not reported
Hyogo College of Medicine Hospital Hyōgo, Japan Site recruitment: Not reported
Tohoku University Hospital Miyagi-Ken, Japan Site recruitment: Not reported
Osaka University Hospital Osaka, Japan Site recruitment: Not reported
Yokohama Municipal Citizen's Hospital Yokohama, Japan Site recruitment: Not reported
Start: 2017-09-27. Completion: 2019-03-20 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teduglutide + Normal Saline (drug) — also listed as: L-NMMA control
Teduglutide + L-NMMA (drug) — also listed as: active treatments
Placebo + L-NMMA (drug) — also listed as: Teduglutide control
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Tornto General Hospital, UHN Toronto, Ontario, Canada Site recruitment: Not reported
Start: 2014-01. Completion: 2015-03 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teduglutide (drug) — also listed as: Gattex, Revestive
Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Mayo Clinic in Rochester Rochester, Minnesota, United States Site recruitment: Not reported
Start: 2009-11. Completion: 2010-04 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teduglutide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Nycomed GmbH Konstanz, Germany Site recruitment: Not reported
Start: 2009-10. Completion: 2010-03 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teduglutide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Nycomed GmbH Konstanz, Germany Site recruitment: Not reported
Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.